Characterization of HMRZ-86: A novel chromogenic cephalosporin for the detection of extended-spectrum β-lactamases [3]

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 888-889

  Hanaki, Hideaki ^a   Kubo, Ryoichi ^b   Nakano, Tomota ^b   Kurihara, Makoto ^b   Sunagawa, Keisuke ^c  

^a KITASATO INSTITUTE   (Japan)

^b KANTO CHEMICAL CO INC   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

lactamase differentiation; Clinical laboratory; disc tests

Indexed keywords

7 [2 (AMINOTHIAZOL 4 YL) 2 (1 CARBOXY 1 METHYLETHOXYIMINO)ACETAMIDO] 3 (2,4 DINITROSTYRYL) 3 CEPHEM 4 CARBOXYLIC ACID TRIFLUOROACETATE; AGAR; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CHELATING AGENT; CLAVULANIC ACID; EDETIC ACID; HMRZ 86; NITROCEFIN; PENICILLINASE; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL LABORATORY; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; LETTER; NONHUMAN; SCREENING TEST;

BACTERIA; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; INDICATORS AND REAGENTS;

EID: 2442681688     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh166     Document Type: Letter

References (6)

1. Kawashima, S., Yamazaki, H., Harada, H. et al. (2002). Cephem compounds and ESBL-detecting reagents containing the same. International Patent Information Number WO02/24707 A1.
2. O'Callaghan, C. H., Morris, A., Kirby, S. M. et al. (1972). Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-8.
3. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
4. Payne, D. J., Bateson, D. A., Gasson, B. C. et al. (1997). Inhibition of metallo-β-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrobial Agents and Chemotherapy 41, 135-40.
5. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
6. Jacoby, G. A. (1998). Epidemiology of extended-spectrum β-lactamases. Clinical Infectious Diseases 27, 81-3.